Real world safety outcomes using cemiplimab for cutaneous squamous cell carcinomaJulie Valentin, Anne Pham‐Ledard, M. Beylot‐Barry et al.|Journal of Geriatric Oncology|2021Cited by 32
Real-World Survival in Patients with Metastatic Melanoma after Discontinuation of Anti-PD-1 Immunotherapy for Objective Response or Adverse Effects: A Retrospective StudyJulie Valentin, E. Gérard, Thomas Ferté et al.|Journal of Oncology|2021Cited by 21
Improved survival over time with immunotherapy in locally advanced and metastatic cutaneous squamous cell carcinomasS. Schneider, Anne Pham‐Ledard, M. Beylot‐Barry et al.|Research Square|2023Cited by 3
Improved survival over time with immunotherapy in locally advanced and metastatic cutaneous squamous cell carcinomasS. Schneider, Anne Pham‐Ledard, M. Beylot‐Barry et al.|Journal of Cancer Research and Clinical Oncology|2024Cited by 2